290 related articles for article (PubMed ID: 15809225)
21. Tet system in the brain: transgenic rats and lentiviral vectors approach.
Konopka W; Duniec K; Klejman A; Wawrzyniak M; Owczarek D; Gawrys L; Maleszewski M; Mallet J; Kaczmarek L
Genesis; 2009 Apr; 47(4):274-80. PubMed ID: 19241392
[TBL] [Abstract][Full Text] [Related]
22. Homogeneity and long-term stability of tetracycline-regulated gene expression with low basal activity by using the rtTA2S-M2 transactivator and insulator-flanked reporter vectors.
Qu Z; Thottassery JV; Van Ginkel S; Manuvakhova M; Westbrook L; Roland-Lazenby C; Hays S; Kern FG
Gene; 2004 Feb; 327(1):61-73. PubMed ID: 14960361
[TBL] [Abstract][Full Text] [Related]
23. Inducible and reversible transgene expression in human stem cells after efficient and stable gene transfer.
Zhou BY; Ye Z; Chen G; Gao ZP; Zhang YA; Cheng L
Stem Cells; 2007 Mar; 25(3):779-89. PubMed ID: 17158240
[TBL] [Abstract][Full Text] [Related]
24. Optimization of the Tet-On system for regulated gene expression through viral evolution.
Zhou X; Vink M; Klaver B; Berkhout B; Das AT
Gene Ther; 2006 Oct; 13(19):1382-90. PubMed ID: 16724096
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
[TBL] [Abstract][Full Text] [Related]
26. Tetracycline-inducible gene expression and gene deletion in Candida albicans.
Park YN; Morschhäuser J
Eukaryot Cell; 2005 Aug; 4(8):1328-42. PubMed ID: 16087738
[TBL] [Abstract][Full Text] [Related]
27. Tight regulation of transgene expression by tetracycline-dependent activator and repressor in brain.
Uchida S; Sakai S; Furuichi T; Hosoda H; Toyota K; Ishii T; Kitamoto A; Sekine M; Koike K; Masushige S; Murphy G; Silva AJ; Kida S
Genes Brain Behav; 2006 Feb; 5(1):96-106. PubMed ID: 16436193
[TBL] [Abstract][Full Text] [Related]
28. Design and in vivo characterization of self-inactivating human and non-human lentiviral expression vectors engineered for streptogramin-adjustable transgene expression.
Mitta B; Weber CC; Rimann M; Fussenegger M
Nucleic Acids Res; 2004 Jul; 32(12):e106. PubMed ID: 15258250
[TBL] [Abstract][Full Text] [Related]
29. Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS.
Zanta-Boussif MA; Charrier S; Brice-Ouzet A; Martin S; Opolon P; Thrasher AJ; Hope TJ; Galy A
Gene Ther; 2009 May; 16(5):605-19. PubMed ID: 19262615
[TBL] [Abstract][Full Text] [Related]
30. Development of ecdysone-regulated lentiviral vectors.
Galimi F; Saez E; Gall J; Hoong N; Cho G; Evans RM; Verma IM
Mol Ther; 2005 Jan; 11(1):142-8. PubMed ID: 15585415
[TBL] [Abstract][Full Text] [Related]
31. Optimization and direct comparison of the dimerizer and reverse tet transcriptional control systems.
Go WY; Ho SN
J Gene Med; 2002; 4(3):258-70. PubMed ID: 12112643
[TBL] [Abstract][Full Text] [Related]
32. Generation and characterization of tTS-H4: a novel transcriptional repressor that is compatible with the reverse tetracycline-controlled TET-ON system.
Bockamp E; Christel C; Hameyer D; Khobta A; Maringer M; Reis M; Heck R; Cabezas-Wallscheid N; Epe B; Oesch-Bartlomowicz B; Kaina B; Schmitt S; Eshkind L
J Gene Med; 2007 Apr; 9(4):308-18. PubMed ID: 17330923
[TBL] [Abstract][Full Text] [Related]
33. Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction.
Belteki G; Haigh J; Kabacs N; Haigh K; Sison K; Costantini F; Whitsett J; Quaggin SE; Nagy A
Nucleic Acids Res; 2005 Mar; 33(5):e51. PubMed ID: 15784609
[TBL] [Abstract][Full Text] [Related]
34. A comparative analysis of constitutive and cell-specific promoters in the adult mouse hippocampus using lentivirus vector-mediated gene transfer.
Kuroda H; Kutner RH; Bazan NG; Reiser J
J Gene Med; 2008 Nov; 10(11):1163-75. PubMed ID: 18773500
[TBL] [Abstract][Full Text] [Related]
35. Doxycycline regulated lentiviral vectors.
Markusic D; Seppen J
Methods Mol Biol; 2010; 614():69-76. PubMed ID: 20225036
[TBL] [Abstract][Full Text] [Related]
36. Elongation factor 1 (EF1alpha) promoter in a lentiviral backbone improves expression of the CD20 suicide gene in primary T lymphocytes allowing efficient rituximab-mediated lysis.
Serafini M; Bonamino M; Golay J; Introna M
Haematologica; 2004 Jan; 89(1):86-95. PubMed ID: 14754610
[TBL] [Abstract][Full Text] [Related]
37. A novel doxycycline inducible autoregulatory plasmid which displays "on"/"off" regulation suited to gene therapy applications.
Gould DJ; Berenstein M; Dreja H; Ledda F; Podhajcer OL; Chernajovsky Y
Gene Ther; 2000 Dec; 7(24):2061-70. PubMed ID: 11223986
[TBL] [Abstract][Full Text] [Related]
38. Glycoprotein Ibalpha promoter drives megakaryocytic lineage-restricted expression after hematopoietic stem cell transduction using a self-inactivating lentiviral vector.
Lavenu-Bombled C; Izac B; Legrand F; Cambot M; Vigier A; Massé JM; Dubart-Kupperschmitt A
Stem Cells; 2007 Jun; 25(6):1571-7. PubMed ID: 17379771
[TBL] [Abstract][Full Text] [Related]
39. Regulated and constitutive expression of anti-inflammatory cytokines by nontransforming herpesvirus saimiri vectors.
Wieser C; Stumpf D; Grillhösl C; Lengenfelder D; Gay S; Fleckenstein B; Ensser A
Gene Ther; 2005 Mar; 12(5):395-406. PubMed ID: 15647772
[TBL] [Abstract][Full Text] [Related]
40. Recombinant expression of coagulation factor VIII in hepatic and non-hepatic cell lines stably transduced with third generation lentiviral vectors comprising the minimal factor VIII promoter.
Picanço V; Heinz S; Bott D; Behrmann M; Covas DT; Seifried E; Tonn T
Cytotherapy; 2007; 9(8):785-94. PubMed ID: 17917890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
